SEC Info - CareMax, Inc. - ‘8-K’ for 3/18/24

SEC Info℠

Home

Help

Please Sign In

CareMax, Inc. – ‘8-K’ for 3/18/24

On: Monday, 3/18/24, at 6:56am ET · For: 3/18/24 · Accession #: 950170-24-32510 · File #: 1-39391

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/18/24  CareMax, Inc.                     8-K:2,7,9   3/18/24    9:1.4M                                   Donnelley … Solutions/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     48K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    841K 
 4: R1          Document And Entity Information                     HTML     53K 
 6: XML         IDEA XML File -- Filing Summary                      XML     11K 
 9: XML         XBRL Instance -- cmax-20240318_htm                   XML     20K 
 5: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 3: EX-101.SCH  XBRL Taxonomy Extension Schema With Embedded         XSD    128K 
                Linkbases Document -- cmax-20240318                              
 7: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    21K 
 8: ZIP         XBRL Zipped Folder -- 0000950170-24-032510-xbrl      Zip    132K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

8-K

i false i 00018139140001813914us-gaap:CommonClassAMember2024-03-182024-03-1800018139142024-03-182024-03-180001813914cmax:WarrantsMember2024-03-182024-03-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i March 18, 2024

i CareMax, Inc.

(Exact name of Registrant as Specified in Its Charter)


i Delaware	i 001-39391	i 85-0992224
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

i 1000 NW 57th Court i Suite 400
i Miami, i Florida		i 33126
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: i 786 i 360-4768

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Class A common stock, par value $0.0001 per share	i CMAX	i The Nasdaq Stock Market LLC
i Warrants, each whole warrant exercisable for 1/30th of one share of Class A common stock	i CMAXW	i The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company i ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. i ☐

Item 2.02 Results of Operations and Financial Condition.

The information contained in Item 7.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.02.

Item 7.01 Regulation FD Disclosure.

On March 18, 2024, CareMax, Inc., a Delaware corporation (the "Company"), issued a press release announcing its financial results for the fourth quarter and twelve months ended December 31, 2023. A copy of the press release announcing the Company's financial results is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

This information and the information contained in Exhibit 99.1 are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in any such filing, regardless of any general incorporation language in the filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits


	Exhibit Index
Exhibit No.		Description

99.1		Press Release issued by CareMax, Inc. on March 18, 2024
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.




Date:	March 18, 2024	By:	/s/ *Kevin Wirges*
			Name: Kevin Wirges Title: Executive Vice President, Chief Financial Officer and Treasurer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	3/18/24	10-K, NT 10-K
	12/31/23	10-K
		List all Filings

↑Top

Filing Submission 0000950170-24-032510 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)